PMID: 2501456Jun 1, 1989Paper

Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease

Journal of Neurology, Neurosurgery, and Psychiatry
P A KempsterG M Stern

Abstract

To assess the relative influence of central pharmacodynamic and peripheral pharmacokinetic factors on the duration of motor response to levodopa, the relationship between motor function and plasma levodopa levels was studied in 31 Parkinsonian patients. Duration of benefit from single levodopa doses while fasting depended on the degree to which the plasma levodopa level had declined over four hours; wearing off occurred when the plasma levodopa level had fallen to approximately 50% of peak concentration, irrespective of the duration of the motor response. Whilst the amplitude of motor response to levodopa is likely to be modified by alternations in dopamine receptor stimulation and sensitivity as the disease progresses, it is proposed that the duration of response is primarily determined by levodopa peripheral pharmacokinetics rather than by central pharmacodynamic factors associated with dopamine storage capacity.

Citations

May 29, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·P Hagell, H Widner
Aug 6, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·K A ReardonP A Kempster
Jun 1, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·R A HauserC W Olanow
Dec 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Craig D McCollPeter A Kempster
Dec 18, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·R CunningtonJ G Colebatch
Nov 25, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·J D O'SullivanA J Hughes
Jan 1, 1995·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·G RansmayrM Falk
Jan 1, 1993·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·M P Caligiuri, S Peterson
Oct 22, 2002·Aging Clinical and Experimental Research·Mati PääsukePille Taba
Jan 25, 2005·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·David S GoldsteinRoy Freeman
Jan 12, 1991·Lancet·A J HughesM Bovingdon
Jun 18, 2002·Journal of Communication Disorders·Alexander GobermanMichael Robb
Apr 23, 2003·Journal of Fluency Disorders·Alexander M Goberman, Michael Blomgren
Jun 28, 2001·Clinical Biomechanics·M E MorrisR Iansek
Jan 29, 2003·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Charles CrevoisierTurid Nilsen
Oct 31, 1998·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·U E GasserJ Dingemanse
Aug 21, 2008·Nature Reviews. Neuroscience·Peter Jenner
Dec 14, 2011·The Neurologist·Maria Cruz Rodriguez-OrozOriol de Fabregues
Jun 1, 1991·Australian and New Zealand Journal of Medicine·P A KempsterI Larmour
Jan 1, 1993·Fundamental & Clinical Pharmacology·A J Lees
Oct 1, 1990·Pharmacology & Toxicology·A FredrikssonT Archer
Dec 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·A J LeesA Rascol
Nov 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·P A KempsterA J Lees
Nov 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·R KapoorR Webster
Nov 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·J P FrankelG M Stern
May 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·J P FrankelG M Stern
Oct 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·B KleedorferN Sree-Haran
Apr 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesG M Stern
Nov 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
Jan 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·R DursoR G Feldman
Feb 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·H S MarkusA J Lees
Apr 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
Nov 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·D E Bateman
Jan 4, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·P C HunterA J Hughes
Dec 1, 1993·The American Review of Respiratory Disease·P F de BruinN B Pride
Jan 21, 2000·Pharmacotherapy·M Stacy
Apr 14, 2010·Expert Opinion on Drug Metabolism & Toxicology·Nelida FernandezMatilde Sierra
Oct 26, 2001·The Australian Journal of Physiotherapy·Meg MorrisAndrew Churchyard
Oct 26, 2001·The Australian Journal of Physiotherapy·Meg MorrisRobert Iansek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.